对于具有离散结果的个性化治疗规则的变量选择
Zeyu Bian1,2, Erica E M Moodie1, Susan M Shortreed3,4
1Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec H3A 0G4, Canada.
我们开发了一种选择重要变量的新方法,以创建个性化治疗规则 (ITR). 这种方法改进了基于观察数据的治疗建议,使其更有效和更容易使用.
科学领域:
- 生物统计学 生物统计学
- 医疗信息学 医疗信息学
- 机器学习 机器学习
背景情况:
- 个性化治疗规则 (ITR) 使用患者特定数据来个性化医疗保健决策.
- 观察性研究通常包括不相关的变量,使ITR开发复杂化并降低效率.
- 有效的变量选择对于强大且可实施的ITR至关重要.
研究的目的:
- 为构建个性化治疗规则 (ITR) 提出一种新的双重可靠的变量选择方法.
- 提高从观测数据获得的ITR的效率和可解释性.
- 评估拟议方法的性能与现有方法相比.
主要方法:
- 为ITRs量身定制的双重可靠的变量选择技术的开发.
- 方法的应用,以确定影响治疗决策的关键变量.
- 在ITRs的背景下,与已建立的变量选择方法进行比较分析.
主要成果:
- 与竞争的变量选择技术相比,提出的双重可靠的方法显示出更高的性能.
- 该方法有效地识别了相关的变量,从而导致更有效和更实用的ITR.
- 使用网络压力管理干预的数据成功说明了该方法.
结论:
- 拟议的双重可靠的变量选择方法在制定有效的个性化治疗规则方面取得了重大进展.
- 这种方法提高了个性化医学的观察数据的实用性.
- 该方法有望改善各种临床和数字健康应用中的治疗建议.
更多相关视频
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
07:35Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
相关概念视频
Randomized Experiments
Simple randomization
Simple...
Woodward–Hoffmann Selection Rules and Microscopic Reversibility
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Comparing the Survival Analysis of Two or More Groups
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
